Severe childhood SMA and axonal CMT due to anticodon binding domain mutations in the GARS gene
This article has been corrected.
VIEW CORRECTIONNovember 14, 2006 issue
67 (9) 1710-1712
Abstract
We screened 100 patients with inherited and sporadic lower motor neuron degeneration and identified three novel missense mutations in the glycyl-tRNA synthetase (GARS) gene. One mutation was in the anticodon binding domain and associated with onset in early childhood and predominant involvement of the lower limbs, thus extending the phenotype associated with GARS mutations.
Get full access to this article
View all available purchase options and get full access to this article.
References
1.
Irobi J, De Jonghe P, Timmerman V. Molecular genetics of distal hereditary motor neuropathies. Hum Mol Genet 2004;13 Spec No 2:R195–R202.
2.
Antonellis A, Ellsworth RE, Sambuughin N, et al. Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am J Hum Genet 2003;72:1293–1299.
3.
Sivakumar K, Kyriakides T, Puls I, et al. Phenotypic spectrum of disorders associated with glycyl-tRNA synthetase mutations. Brain 2005;128 (pt 10):2304–2314.
4.
Pearn J. Autosomal dominant spinal muscular atrophy: a clinical and genetic study. J Neurol Sci 1978;38:263–275.
5.
Del Bo R, Locatelli F, Corti S, et al. Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology 2006;66:752–754.
6.
Park SG, Ewalt KL, Kim S. Functional expansion of aminoacyl-tRNA synthetases and their interacting factors: new perspectives on housekeepers. Trends Biochem Sci 2005;30:569–574.
7.
Johanson K, Hoang T, Sheth M, Hyman LE. GRS1, a yeast tRNA synthetase with a role in mRNA 3′ end formation. J Biol Chem 2003;278:35923–35930.
8.
Jordanova A, Irobi J, Thomas FP, et al. Disrupted function and axonal distribution of mutant tyrosyl-tRNA synthetase in dominant intermediate Charcot-Marie-Tooth neuropathy. Nat Genet 2006;38:197–202.
Information & Authors
Information
Published In
Neurology®
Volume 67 • Number 9 • November 14, 2006
Pages: 1710-1712
Copyright
© 2006.
Publication History
Published online: November 13, 2006
Published in print: November 14, 2006
Authors
Metrics & Citations
Metrics
Citations
Download Citations
If you have the appropriate software installed, you can download article citation data to the citation manager of your choice. Select your manager software from the list below and click Download.
Cited By
- Dominant aminoacyl-tRNA synthetase disorders: lessons learned from in vivo disease models, Frontiers in Neuroscience, 17, (2023).https://doi.org/10.3389/fnins.2023.1182845
- Clinical, Genetic, and Disability Profile of Pediatric Distal Hereditary Motor Neuropathy, Neurology, 96, 3, (e423-e432), (2023)./doi/10.1212/WNL.0000000000011054
- Large-scale detection and characterization of interchromosomal rearrangements in normozoospermic bulls using massive genotype and phenotype data sets, Genome Research, 33, 6, (957-971), (2023).https://doi.org/10.1101/gr.277787.123
- Aminoacyl-tRNA synthetases in human health and disease, Frontiers in Physiology, 13, (2022).https://doi.org/10.3389/fphys.2022.1029218
- A missense, loss-of-function YARS1 variant in a patient with proximal-predominant motor neuropathy , Molecular Case Studies, 8, 7, (a006246), (2022).https://doi.org/10.1101/mcs.a006246
- Pathogenic missense variants altering codon 336 of GARS1 lead to divergent dominant phenotypes , Human Mutation, 43, 7, (869-876), (2022).https://doi.org/10.1002/humu.24372
- Impaired Mitochondrial Mobility in Charcot-Marie-Tooth Disease, Frontiers in Cell and Developmental Biology, 9, (2021).https://doi.org/10.3389/fcell.2021.624823
- Associations between Neurological Diseases and Mutations in the Human Glycyl-tRNA Synthetase, Biochemistry (Moscow), 86, S1, (S12-S23), (2021).https://doi.org/10.1134/S0006297921140029
- tRNA overexpression rescues peripheral neuropathy caused by mutations in tRNA synthetase, Science, 373, 6559, (1161-1166), (2021).https://doi.org/10.1126/science.abb3356
- AAV1.NT-3 gene therapy in a CMT2D model: phenotypic improvements in GarsP278KY/+ mice , Brain Communications, 3, 4, (2021).https://doi.org/10.1093/braincomms/fcab252
- See more
Loading...
View Options
Get Access
Login options
Check if you have access through your login credentials or your institution to get full access on this article.
Personal login Institutional LoginPurchase Options
Purchase this article to get full access to it.